NEUROPROTECTIVE EVALUATION OF OCCIDENTALIN-1202 PEPTIDE IN A MURINE MODEL OF PARKINSON'S DISEASE.

- 320887
Abstract
Favorite this paper
How to cite this paper?
Abstract

Introduction: Parkinson's Disease (PD) is characterized by the selective loss of dopaminergic neurons in the Substantia Nigra (SN) region. The main treatment involves the use of levodopa, but the drug only provides symptomatic relief and does not prevent the progression of the disease. Wasp venoms are the product of long term evolutionary pressure, resulting in highly specific molecules with significant pharmacological potential. Previous studies with the OcTx-1202 peptide have shown antiepileptic and neuroprotective activity.

Objective: The purpose of this study was to investigate the antiparkinsonian effect of the OcTx-1202 peptide in a mouse model of parkinsonism, using three different doses (1, 2.5, and 4 mg/kg).

Methods: The study was conducted after approval by the Ethics Committee on Animal Use of the University of Brasília, according to protocol UnBDoc no. 79100/2014. Were used male swiss mice for the study and kept under controlled light conditions and temperature. The Occidentalin-1202 peptide (OcTx-1202), with the sequence Glu-Gln-Tyr-Met-Val-Ala-Phe-Trp-Met-NH2, presenting an identical sequence to the natural peptide.

For the experimental model, animals were divided into three groups: 6-OHDA (parkinsonism + vehicle), OcTx-1202 (parkinsonism + peptide at three doses), and healthy (healthy + vehicle). Behavioral tests consisted in the Rotarod for motor activity (6-hour evaluation) and apomorphine-induced rotation. Subsenquently, immunohistochemistry was conducted to quantified viable neurons in the SN.

Results: Regarding the immunohistochemical, the peptide was not able to reduce neuronal death. However, in the motor coordination test on the Rotarod, animals that received the dose of 4 mg/kg showed improvement in motor condition after 60 minutes from the last administration of the treatment (p<0.0001). Additionally, in the apomorphine test, both doses of 2.5 and 4 mg/kg decreased the number of rotations (p<0.001).

Conclusions: These results suggest that the OcTx-1202 peptide may have a positive effect on improving motor symptoms associated with Parkinson's disease. However, the assays conducted did not show a significant neuroprotective effect of the peptide.

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 University of Brasília
Track
  • Peptides and neurological disorders
Keywords
Parkinson’s disease
Peptides
wasp venom
6-hydroxydopamine
neuroprotection